Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

(Reuters) - European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo ...

GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism around its ...

To understand how the Mayo Clinic became a superior healthcare brand, I talked with Leonard Berry, PhD, to understand their ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

She was previously the supplier's head of commercial excellence for Europe, Middle East, Africa & Latin America ...

The sharp decline in consumer confidence this month follows the decrease that began last month, marking a substantial drop after several months of improvement due to falling interest rates. This month ...

We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

The decline in Hindustan Unilever shares this year has helped improve its multiples. The stock is currently trading at 46 times its forward earnings, below its five-year average of about 54 times ...